Thursday, 8 October 2026
Venture Intelligence News

M&A M&A

Pharma co. Lupin acquires diabetes drug Huminsulin in India from US co. Eli Lilly

Source Business Line (opens in a new tab)

Mumbai-based, publicly-listed drugmaker Lupin Ltd has acquired Huminsulin in India from Indiana, USA-based Eli Lilly and Company.Lupin has been marketing the Huminsulin range of products through existing distribution and promotion agreements with Eli Lilly.

Company website ↗ (opens in a new tab)